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This article presents an overview of cost issues related to AIDS.

Data from

the

Massachu-

Cost of AIDS Study are combined with epidemiological projections to estimate the
cost of treating people diagnosed with AIDS in New England. Aggregate inpatient, ambu-

setts

and home care costs are estimated to be $96. 9 million and $524. 8 million through
1987 and 1991, respectively. These estimates represent a relatively small percentage of
total health care costs for all illnesses over the same time period.
The authors find that the cost of treating AIDS does not affect all health care providers
uniformly and therefore argue that appropriate measures must be developed to assist those
latory,

impacted disproportionately. Reduction of inpatient hospital days through the creation of
subacute care centers, subsidy programs for medical care providers serving large numbers
of uninsured or underinsured AIDS patients and education to prevent new cases are recommended to continue the availability of medical care for people with AIDS.

growing number of AIDS
The
increased
of
rapidly

interest in the cost

future cases

1991

— the number

is

cases in the United States has generated an

treating patients with

HTV

infection. Projections of

expected to exceed 270,000 for the nation as a whole by

— are a warning to legislators, insurers, employers, health care and policy planners,

and health care activists to prepare for the
economic impact of AIDS. One of the most frequent questions asked of public health
hospital administrators, private practitioners,
1

programs

officials regarding treatment

The

for people with

AIDS

is,

How much will it cost?

AIDS are usually considered from the perspective
With regard to cost, the key questions are, How much will
pay the cost? To what extent can society afford to pay the cost? From the

health care needs of people with

either of cost or of utilization.
it

cost?

Who will

perspective of utilization, the important issues are related to the availability of resources:

What types

of resources do

AIDS patients

Will they be available to meet future

need? Are these resources available currently?

demand?

Stewart J. Landers is project director of the Massachusetts Cost of AIDS Study. George R. Seage III is the senior
AIDS epidemiologist for the Boston Department of Health and Hospitals and is principal investigator of the
Massachusetts Cost ofAIDS Study.
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Questions about cost and utilization of services merge in the areas of planning and
budgeting. While there

is little

cost of treating people with

doubt that the resource utilization and the accompanying

AIDS are large and will get significantly

likely that, given adequate planning, cost-effective resources

larger,

it is

also

can be identified to meet

this need.

In this article, the authors stress that information about cost
the provision of AIDS care.

The

text is divided into three

is critical

main

sections.

reviews information currently available on the cost of services in
cally in Massachusetts. Inpatient, ambulatory,

indirect costs of care are discussed.

may

to planning for

The

first section

New England,

specifi-

and home care costs are described. The

These indirect costs include some hidden costs

that

represent the largest costs of the epidemic. Changes in the cost of treating people

with AIDS are discussed. The section concludes with estimates of the cost of treating
AIDS in New England up to 1988 and cumulatively through 1991
The second section describes the payer mix of AIDS patients and the anticipated impact
of the projected AIDS crisis on each type of payer. People with AIDS must do battle with
private and public insurance

programs

to receive coverage for their care. Public

and pri-

vate insurers, as well as hospitals providing free care, struggle to act responsibly in the

face of this epidemic without overextending themselves financially.

The

third section discusses the implications of health care costs in planning for the

provision of health care for people with AIDS.
ity,

The

section addresses issues of insurabil-

cost containment, and prevention, and targets specific areas

where planning

sary to provide humane, comprehensive, and quality care to persons with

is

neces-

AIDS.

The Cost of Treating Patients with AIDS
The

initial

report on the cost of treating patients with

AIDS estimated a cost of $147,000

per patient. 2 Subsequent studies in San Francisco and Massachusetts found that medical
care costs were significantly lower. 3

4

A review of cost studies by the federal Office for

Information Technology reported lower costs in studies from Maryland,

New York, New

Mexico, Alabama, Minnesota, Florida, and California. 5 Research from a hospital in Vir6

ginia and the first

two national studies with a wide sample of data7

firmation that direct medical care costs are lower than the

8

provide further con-

initial estimate,

probably in the

range of $20,000 to $60,000.

Cost in Massachusetts
In Massachusetts, a study to determine the costs of treating

AIDS was begun in February

The study was sponsored by the state Department of Public Health and was conducted by the public health AIDS program of the Boston Department of Health and Hospi1985.

tals.

In that study, the authors of this article and their colleagues evaluated forty-five

AIDS patients

seen at the

New England Deaconess Hospital between March

1984 and

February 1985. 9
Inpatient and outpatient medical
zation,

and demographic

were used

data.

and billing records were reviewed

to obtain cost, utili-

Data from the Massachusetts Rate Setting Commission

to convert inpatient charges to costs.

Charges for ambulatory care were con-

verted to costs through the use of Blue Cross customary reimbursement rates.

On the basis of these data,

the researchers calculated an average hospitalization cost of

$14, 189 and an average length of stay of 21 days per hospitalization. To answer a variety

258

of questions, the authors also calculated cost per patient per
as $46,505,

and costs per case, from diagnosis

annum (twelve-month period)

$50,380. 10

to death, as

Analyses of the data also yielded the number of hospitalizations per patient as 1.6; hospitalizations per patient per

annum,

3.3; hospital days per patient, 33;

and hospital days

per patient per annum, 62.

Components of Inpatient and Ambulatory Care
In the aforementioned cost study, the researchers analyzed the components of inpatient

and ambulatory care
are concentrated.

to

The

determine where the medical expenses of treating

results of this analysis (table 1)

ing 89 percent of total costs incurred by

show

AIDS patients,

AIDS patients

that inpatient costs, constitut-

am-

are dramatically higher than

bulatory costs.
Total ancillary services, including laboratory services,

cent of all inpatient care costs for the patients with
ancillary services

is

AIDS

were responsible

for 47.9 per-

studied. This percentage for

not unusual for patient care costs generally. However, the high labo-

component of ancillary services is greater for AIDS patients than for non-AIDS
patients. Room and board (routine and intensive care) and laboratory services comprised
the two largest categories of cost, representing 45 and 22 percent, respectively, of total
ratory

inpatient care costs.

Cost for laboratory services and cost of professional services accounted for 56 and 16.9
percent, respectively, of all ambulatory care costs.
tory services

and

is

The

large percentage of cost in labora-

related to the close monitoring of patients'

immune

status for diagnostic

palliative purposes.

Home Care and Support Services
Very few studies have analyzed both the cost and the cost-effectiveness of services

that

AIDS to spend more time at home and, presumably, less time in acute
However, a study of thirty-seven pediatric AIDS cases in New York City

allow people with
care settings.

identified 1,909 hospital days that the researchers labeled "social admissions"

patient days in acute inpatient care facilities resulting

from lack of appropriate

— that

is,

available

placement. 11 These so-called social admissions represented 31 .2 percent of hospital days
for this cohort of pediatric

the hospital, the

AIDS

cases. Thus, if adequate services

were

number of hospital days could be drastically reduced

available outside

for this cohort.

A San Francisco study of both paid and volunteer home care services showed that home
care was significantly less expensive than hospital-based care. 12

Among the resources

program provided a range of home
care services to persons with AIDS which enabled them to spend most of the duration of
their illness, including the terminal stage, at home. For the 165 persons with AIDS who
evaluated was a home-based hospice program. This

received care under this program, the study found that they required an average of 47

hospice days per person, at an average cost of $4,401 per patient. The average cost per

day of hospice care was $94, compared to an inpatient cost per day
eral Hospital of $773.

13

at

San Francisco Gen-

Additional data from San Francisco estimate the cost of acute

inpatient care at $800/day; subacute care at $500/day; skilled nursing facility at $300/

day; residential hospice at $100/day; and nonmedical group residence at $50/day. 14

To evaluate home care needs and utilization,
Massachusetts were surveyed. 15
clients of the

clients of the

AIDS Action Committee of

A questionnaire was mailed in the spring of 1986 to

AIDS Action Committee and was returned by 43

259

individuals.
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Table 1

Total Cost per Patient for
Total Cost

AIDS Medical Care*

by Components

Service Area

Cost

(U.S. $)

Inpatient cost
Outpatient cost
Outpatient cost (related to
research protocol)

22,097

(89.2)

1,907

(7.7)

760

(3.1)

Total

24,764

Inpatient Cost by

Cost

Room cost
Laboratory

Pharmacy
Supplies
X-ray
Professional cost

Intensive-care

(100)

Components

Service Area

room cost

Therapy
Operating room cost
Miscellaneous

(U.S. $)

Outpatient Cost by

(41.5)

845
622
454

(3.8)

15

(0.1)

(21.7)
(13.4)
(5.1)
(5.0)
(4.6)

(2.8)
(2.1)

(100)

Components

Service Area

Cost (U.S.

Laboratory
Professional charges

Surgery

Pharmacy
Therapy
X-ray
Miscellaneous

Emergency room

$)

(%)

1,493

(56.0)

452
254
229
136
64
29

(16.9)

11

visits

2,668

Total

*George R. Seage III, Stewart Landers, et al., unpublished data from study
45 AIDS patients at New England Deaconess Hospital 1984-85.

(9.5)
(8.6)

(5.1)
(2.4)
(1.1)
(0.4)

(100)

of cost of treating

to

determine the average weekly utilization of home care services.

results indicate that

65 percent of respondents used or needed some home care serv-

the questionnaire

ices.

(%)

9,176
4,786
2,958
1,126
1,099
1,016

22,097

Total

The

(%)

was

The researchers determined a mean utilization

cost of $107 per week, applying Blue

home care services. Assuming
home care except when they are hospitalized, the cost of
for a person with AIDS from diagnosis to death may be estimated to

Cross reimbursement rates to estimate the cost of these
that persons with

home care

AIDS

services

receive

be $4,985. 16
This figure

may be based on an underestimation of home care utilization. Those indi-

viduals needing the greatest

amount of care were

260

the least likely to respond to a question-

naire.

However,

the estimate

is

pice care in San Francisco and

almost identical to the estimated cost of home-based hos-

may be used as

a rough approximation of home care costs.

A thorough, population-based study of the utilization of home care health services by
AIDS patients needs to be performed.
Indirect Costs

Scitovsky and Rice have divided the indirect costs of AIDS into two types: morbidity
costs (productivity lost

those

on account of illness) and mortality

who die prematurely). They
17

costs (future earnings lost for

estimated the total direct and indirect cost of AIDS in

the United States in 1985 alone to be $4.8 billion.

Of this cost,

the researchers calculated

$3.9 billion, or 81 percent, as indirect costs. Thus, while indirect costs are less obvious in

terms of impact upon the health care system, the overall economic impact of such indirect
costs

is

immense.

Mortality costs account for 94 percent of indirect costs. These costs are very high,

owing to the young age of AIDS patients and the associated large numbers of years of life
lost. Not included in this accounting is the fact that many persons with AIDS may not pay
premiums to health insurance, taxes, Social Security, and so on, during what are usually a
person's most productive years.
Other indirect costs related to the cost of AIDS include added infection control precau18
tions, nursing care, and supplies, as well as complex case management services. The
difficulty of caring for AIDS patients consists in increasing personnel costs, owing to the
need for additional support services for personnel. This
rect costs of AIDS in

its

article will not include the indi-

projections of direct medical care costs in

Changes in the Cost of Treating AIDS
The cost of providing medical care to a person with AIDS
that the cost

may be declining. New and costly therapies

is

not

New England.

static.

There

for persons with

is

evidence

AIDS,

as well

as experience in the treatment of AIDS, will affect the cost of care.

Evidence of reduction in cost. In July 1985, the study of the cost of treating persons
AIDS in Massachusetts expanded to include five hospitals and to evaluate patient

with

utilization

over the two-year period March 1984 through February 1986. 19

Two hundred

and forty patients were enrolled over the two-year period. This cohort represented 55

AIDS patients alive in Massachusetts during the study period. The cohort
was representative of all AIDS patients reported to the Massachusetts AIDS Surveillance
Program with regard to risk group status, gender, geographical distribution, and race.
Preliminary data on cost over the two-year period showed a decline in total inpatient
and outpatient cost from year one to year two at each of the five hospitals studied. The
researchers attributed the observed decrease both to shorter lengths of stay (mean reduced
from 19.2 days/hospitalization to 15.7 days/hospitalization) and to a decrease in the mean
number of hospitalizations (mean reduced from 2.2 hospitalizations/patient to 1 .9 hospi-

percent of all

talizations/patient). Future analysis

of these data will attempt to evaluate additional fac-

tors related to the decline in cost, such as the availability of support services

and home

care programs.

The effect on cost ofALT. As antiviral and other therapies are developed, the direct
medical care cost of treating AIDS is likely to change. One therapeutic agent that may

have a significant impact on cost of care is the drug Azidothymidine (AZT). It is uncertain whether use of this drug, which has been shown to decrease the frequency of lifethreatening

pneumonia

in

AIDS patients,

will increase or decrease utilization of health

261
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care services.
the overall

20

AZT may reduce the length of stay for AIDS-related hospitalizations and

number of hospital days

portunistic infections.
to continue

On the

for

AIDS

patients,

by decreasing the severity of op-

AZT may also keep AIDS patients healthier longer and allow them

working longer.

more bouts of Pneumocystis carinii
pneumonia (PCP), AZT may result in more lifetime hospitalizations and an increased
number of total hospital days. In addition, physicians may become more aggressive in
their treatment, knowing there is a drug that may significantly extend the patient's life
other hand, by allowing patients to survive

once any immediate

One

thing

is

crisis is forestalled.

certain:

AZT is an expensive drug. A one-year supply of AZT is currently

:i
estimated to cost between $8,000 and $10,000.

continue taking the drug as long as he or she

AIDS patients. The

Experience with
patients

may

alter the cost

Once on AZT, an AIDS

is alive,

patient needs to

unless serious side effects occur.

extent of an institution's experience with

AIDS

of services to persons with

for a

AIDS

number of reasons,

including familiarity with the disease; adoption of an oncological modality of treatment;

and recognition of the particular out-of-hospital services

The lack of familiarity with

the care required

AIDS patients may require.
AIDS may lead to unnec-

that

by persons with

A report on the provision of medical care at U.S. public and

essary cost expenditures.

private teaching hospitals found that 15 percent of responding hospitals had not yet
treated an

AIDS patient.-

require will reduce the

Familiarity with the care and support that persons with

number of hospital

AIDS

days, the use of intensive care, and the applica-

tion of unnecessary diagnostic techniques.

As AIDS

is

a

new and thus

far terminal illness,

AIDS

care

may utilize a range of differ-

ent treatment modalities. For example, an alternative to the inpatient hospital

oncological or hospice model. This model, developed for terminally

ill

model

is

the

cancer patients,

attempts to maximize comfort for the afflicted individual and rmnimize aggressive or
intrusive diagnostic

much less

and therapeutic measures.

AIDS patients

be placed under intensive care

likely to

receiving hospice care are

— an unpleasant (albeit potentially

life-

prolonging) and costly form of care.

The

availability of support services

and home care can make a difference

in the length

of hospitalizations and the overall cost. In some cases, discharge planners need to familiarize themselves with the services

AIDS. However,

and support groups already available

to persons with

many local communities may prevent the
home care plan.

the absence of such services in

implementation of an effective and

Estimating Cost in

realistic

New England

For purposes of estimating direct medical care costs per case, the authors have combined
the

mean

inpatient

care cost, $4,985.

and ambulatory cost per case, $50,380, and the mean estimated home

Our estimated total

direct medical care costs per case are $55,365.

The number of AIDS cases diagnosed
to the Centers for

Disease Control

23, 1987 (see table 2). Nationally,

to date in

New England is based on case reports

(CDC) by the six New England states as of November
more than 270,000 cases are expected by the end of

1991 Massachusetts has consistently reported 2 percent of the national cases, and
.

percentage

is

Projections for the other five

each

state

this

used to estimate the case load in Massachusetts cumulatively through 1991

New England

has reported cumulatively to

England cases each such

states are

based on the

November 23,

total represents.

total

Using these calculations, the

262

number of cases

1987. and the percentage of
total direct

New
medi-

.

cal care cost is

AIDS

$524.8 million for persons with

diagnosed in

New England during

the ten-year period 1981 to 1991.

Who Will Pay? A Look at the Payers
With an estimate of $524. 8 million needed to pay for the direct medical cost of treating
AIDS in New England through 1991 (see table 2), the most important questions are, Who is and who will be paying for this, and who will pay in the future? The
simple, if somewhat naive, answer, of course, is that we all pay for the cost of treating
AIDS, either through health insurance premiums, federal and state tax dollars for Medicare and Medicaid, or local tax revenue that provides services to the uninsured or reimbursements to hospitals for free care and bad debt. The reason this point of view is naive
is that the exact payer mix matters greatly to each potential payer. Insurers wish to reduce
their exposure to high costs; holders of private insurance policies do not want their premiums to rise; and government health care budgets need to remain responsive to a wide
persons with

variety of political interests. In essence,

between the private versus the public
Analysis of the payer mix

is

key

to

AIDS

costs highlight the classic confrontation

sector.

measuring the impact of policies that will

shift the

AIDS patients among payers. The Massachusetts cost study found that
47 percent of people with AIDS had Blue Cross, 18 percent had commercial insurance,
cost of caring for

23
18 percent had Medicaid, and 18 percent had no insurance. These data differ from the

They reported that
were reimbursed by private
insurance. Instead, 65 percent of patients had Medicaid, 17 percent had no insurance, and
1 1 percent had Medicare, received veterans' benefits, were prisoners, or were classified
data presented by Andrulis and Beers et

al.

in their nationwide study.

for hospitalizations in the Northeast region, only 12 percent

as "other."

24

Table 2

AIDS Cases and Costs*

Cost of AIDS

Cost of AIDS

AIDS Cases

AIDS Cases

Diagnosed

Diagnosed

Diagnosed

Diagnosed

to1 1/23/87

State

to 11/23/87"

Massachusetts

997

Connecticut

521

Rhode

105
57
49

Island

Maine
New Hampshire
Vermont
Totals

New England States

in

to 1991

5,400
2,822

21

(57.0%)
(29.8%)
(6.0%)
(3.3%)
(2.8%)
(1.2%)

1,750

(100.0%)

9,497

b

(in

to 1991
(in

$millions) c

5.8

299.0
156.2
31.5

3.2

17.1

2.7

14.7

1.2

6.3

96.9

524.8

55.2
28.8

569
309
265
114

*Costs include hospital inpatient, hospital outpatient, and

$millions) c

home care costs.

Note: Projections are likely to vary by as much as 50 percent; any variation between these projections and those
found in other articles is due to different assumptions about the number of infected persons, the spread of infection,
and the rate at which those infected will progress to AIDS.

*AIDS Weekly Surveillance Report
Centers for Disease Control,
b

W. M. Morgan and
Health Reports

1

J.

W.

— United States, United States AIDS Program, Center for Infectious Diseases,

November 23,

1

987,

2.

Curran, "Acquired Immunodeficiency

01 , no. 5 (September-October

1

Syndrome: Current and Future Trends," Public

986): 461

cCosts data are based on George R. Seage III, Stewart Landers, Anita Barry, et al., "Medical Care Costs of
Massachusetts," Journal of the American Medical Association 256, no. 22 (December 12, 1986): 3107.
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The wide discrepancy is due to the difference between the two cohorts. The initial Maswas comprised predominantly of white, gay men, most of whom were
working at jobs that provided health insurance at the time they became ill. Andrulis and
sachusetts study

Beers

et al. studied costs at

public hospitals and teaching hospitals, and their Northeast

New York and New Jersey as well as New England. The number of persons with AIDS in New England who rely on the public health system may range from 36

region includes

percent to almost 90 percent.

Private Insurers

Concern about AIDS costs

is

not uniform

among private insurers. Some private payers

are devising strategies to reduce their exposure to AIDS-related costs.
rise

of widespread health insurance, as well as

its

A quick look at the

recent decline, sheds light on the con-

cerns of the industry.

The growth of health insurance in the United States from the time of World War II to
is well documented by Rashi Fein, an expert in medical economics at the

the present

Harvard School of Public Health:
[By 1977,] over 80 percent of total health insurance premiums went for the purchase
of group coverage and over 95 percent of all group insurance was provided in the

employment context. Furthermore, almost 90 percent of all U.S. employees worked
in firms that provided health insurance plans and over 90 percent of employees in
those firms were eligible for the insurance. 25

However, Fein

also notes:

In 1977 over 99 percent of workers in firms with over

1

,000 employees had an em-

ployment-related health insurance plan, compared with only 55 percent of workers in
firms with 25 or fewer employees. ... In general, workers in smaller and nonunionized firms were less likely to have employment-related group coverage. 26

Group

health insurance

is

usually provided without any physical

testing. After a fixed waiting period, the

ing conditions he or she

employee

is

exam or laboratory

covered regardless of any preexist-

may have. As a member of a group insurance plan,

an individual

cannot be denied coverage as a result of HIV testing or other prescreening method em-

ployed by insurers for persons seeking individual coverage.

Under the Consolidated Omnibus Budget Reconstruction Act of 1985 (COBRA), permore employees have the right to continue insurance for a period of eighteen months following
27
termination of employment. Individuals must pay the full cost of premiums. COBRA
sons covered by group health insurance policies in companies of twenty or

also requires that individuals are informed of this right,

which enables AIDS patients

to

prolong the time period during which their financial resources are protected from the cost

of high medical expenses.
In the 1980s, a significant decline in the availability of group health insurance has oc-

To protect against rising costs, employers frequently exclude family members
and part-time employees from group health policies or require higher co-payments, leav-

curred.

ing fewer individuals covered by insurance.

Furthermore, a growing number of companies, especially larger firms, no longer offer

commercial policies and are

self-insuring. Eighty-five percent of firms with

forty thousand employees and 70 percent of firms with between twenty and

264

more than

thirty thou-

sand employees are

now

self-insured.

28

Self-insured groups are covered under the federal

Employee Retirement Income Security Act (ERISA) and are exempt from
tion.

There has been no federal

AIDS;

state regula-

insurance coverage for persons with

initiative to protect

therefore, employers that are self-insured have greater discretion regarding deci-

sions to test for the

AIDS

antibody or to not cover

AIDS at all.

In addition, because these

employers are not subject to state attempts to pool higher health insurance risks, they

undermine the limited experimentation with shared

risk pools.

Health Maintenance Organizations (HMOs), a relatively

new

entrant into the health

HMOs are concerned that HIVantibody -positive persons with a choice of insurers will select HMOs to reduce the high
care market, have shaped health care policy significantly.

co-payments required by many traditional health insurance policies.
Public-Sector Insurance

The reduced availability of private health insurance underscores
caid as an insurer of last resort for

AIDS patients

in

the importance of Medi-

New England.

Medicaid

eligibility is

dependent upon income and assets. If a person has assets in his or her name, those resources must be depleted in order for that individual to qualify. States have a wide variety

of criteria for Medicaid

eligibility.

For example, Andrulis and Beers

et al.

found that only

15 percent of AIDS cases in the South are paid for by Medicaid. 29 This figure
to the restrictive

Medicaid

eligibility

Individuals under age sixty-five

requirements

become eligible

common among
for

Medicare

is

attributed

southern states.

after they

have received

Social Security Disability Insurance (SSDI) for twenty-four consecutive months, fol-

lowed by a processing period of three to five months. However, the median conditional
from date of diagnosis with AIDS is 347 days. 30 Thus, most per-

probability of survival

sons with

AIDS

AIDS never qualify

diagnosis

is

for Medicare. In 1985, Massachusetts determined that an

a presumptive disability, which qualifies persons with

AIDS

for

SSDI.

However, with the recently expanded case definition, certain AIDS diagnoses, including
wasting syndrome and dementia, no longer automatically qualify an individual for SSDI.
Currently, Medicare pays for the care of approximately 1 to 2 percent of AIDS patients
in Massachusetts, but it could pay for more. There exists a waiver of the two-year Medicare waiting period for individuals with certain types of renal disease. If a similar waiver

were available for AIDS patients, the cost of treating them would shift dramatically from
Medicaid to Medicare, and consequently from the state to the federal government. Further analysis is necessary to demonstrate the magnitude of this cost shift if the waiting
period were eliminated or if it were reduced to six, twelve, or eighteen months.
Implicit in a state-controlled

program

is

the

power to determine what will or will not be
The

covered. Such decisions are likely to reflect political as well as medical realities.

AZT, for example, is likely to depend as much
on political will as on economics. Medicaid in Massachusetts, as in most states with large
and visible advocacy groups representing persons with AIDS, has decided that it will pay
decision of a Medicaid program to pay for

for

AZT.

Free Care
Despite the availability of Medicaid and the advent of client advocates to help people

many individuals continue to fall through the cracks
and seek medical care without any insurance coverage. In Massachusetts, a reimbursement system (Chapter 572) was established to cover hospital losses resulting from free
enroll in publicly funded programs,

265
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care.

The system, which expired October

1,

1987, allowed hospitals to set charges in

excess of expenses in order to cover free care.

Some other New England

states

do not

reimburse hospitals for free care.

A large number of persons with AIDS do not have health insurance and therefore tax
the system to reimburse free care. Thus, the

AIDS

epidemic has a disproportionate im-

pact on those hospitals seeing the greatest numbers of AIDS patients. Boston hospitals

reported 79 percent of Massachusetts cases, although only 47 percent of Massachusetts
cases actually reside in Boston.

The concentration of cases

at these hospitals invalidates

the equations previously used to compensate these institutions.

The AIDS epidemic
and Medicaid
this

patients.

will increase the

For hospitals

need for services among uninsured, underinsured,

that continue to provide care for indigent patients,

epidemic will mean a rise in free care. Government must ensure the willingness and

financial ability of hospitals to care for indigent patients.

Issues Affecting Cost

and Treatment

The direct medical care
fiscal

costs of treating persons with

planning efforts of health care planners in

AIDS present a challenge to the

New England.

In relation to overall na-

tional health expenditures, the actual cost of treating persons with

tovsky and Rice estimate that in 1991
national medical care costs.

31

AIDS

,

will represent

1

AIDS

.4 percent

is

small. Sci-

of estimated

This relatively small percentage could be absorbed

distributed evenly across all insurers

and providers of care. However,

in order to

if it

were

tame the

become unevenly distributed in society.
new methodologies for cost containment. In the
such as family members — have effectively been

rise in health care costs, access to health care has

The health care industry

is

developing

process, certain population groups

—

denied access to medical care; some employers provide very limited options that deny

employees

full

coverage. These disenfranchised groups are already taxing the public

health care system.

With the addition of AIDS treatment,

certain providers

may be totally

crippled.

A new movement to protect access to health insurance is developing nationwide in
response to the cost containment practices in the health care industry. Advocates of compassionate health care must couple arguments for wider access to care with plans for cost

containment. Without cost containment, plans to increase access to health insurance do
not appear to be politically viable. In Massachusetts, Governor Dukakis has led a move-

ment

for universal health insurance but as of this writing has not succeeded in passing

legislation for this purpose.

32

some form of universal health insurance is enacted, the marketplace for health
become increasingly restrictive. For persons with AIDS or who are infected
with HIV, the available options may become fewer as the need for insurance becomes
Until

care will

greater. In the next section,

ing the

AIDS

we look at the developments

in health insurance

which

AIDS. The section concludes with suggestions
adverse economic impact of AIDS on the health care system.

persons with

or at risk for

Developments in Health Insurance
Various developments in health insurance may
cost of care.

HIV antibody

source of payments as well as the

screening will shift responsibility for the cost of caring for

AIDS from private insurance to the public
facilities will shift

alter the

affect

for reduc-

sector. Insurance

coverage of subacute care

medical care services to less cost-intensive alternatives. Shared risk
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pools are one mechanism for maintaining private insurer involvement in the care of persons with AIDS.

HIV antibody testing.

Insurers have sought the right to screen applicants for health

insurance for evidence of HIV infection. Screening for
initiated for

group health insurance, since no

eligibility

HIV

antibody status has not been

screening practices are currently

due to AIDS become unmanageable, insurers
HIV infection under group plans. In Massachusetts,
hearings on proposed regulation of the use of the HIV antibody test reflected widespread
in place for

may

group plans.

If insurance losses

increase efforts to screen for

consensus among
insurance

all

eligibility.

constituencies, except insurers, against the use of the test for health
33

This view

is

that health insurance is a necessity

consistent with a widespread opinion in Massachusetts

and should be considered a basic individual

right.

The Massachusetts Division of Insurance had, until September 1, 1987, prohibited
insurers from using the HIV antibody test at all. The division then promulgated and
adopted regulations allowing limited use of the

test for individual life

and

disability insur-

ance plans. The regulations also provided for limited confidentiality of test results and for
required counseling of persons

who tested positive. Upon challenge by the insurance

industry, a preliminary court decision held that the regulation

power by
will

is

34

At the present time, it
recognize an administrative or regulatory ban on antibody
the insurance commissioner.

an invalid exercise of

is

uncertain whether courts

testing without special

enabling legislation.
Fairness and excessive losses are the main arguments offered by insurers to justify

screening out HIV-infected individuals for health insurance. Insurers argue that
are forced to assume the high cost of insuring HIV-infected persons, individual
will increase.

Any rise in premiums,

they contend, will force individuals

gling to maintain individual policies to give
ity

of individuals with

up those policies. Therefore,

HIV infection or AIDS

is

if

they

premiums

who are strugif

the insurabil-

protected, other individuals

may be

deprived of health insurance. Furthermore, since insurance companies currently refuse

— such as former cancer patients, women with certain types of
and others — insurers argue would be unfair to insure HIV-infected

insurance to "bad risks"

benign cysts,
persons

35

it

who are comparably bad risks. However,

state

governments, for public policy

reasons, have successfully constrained insurers from using other tests, including those

which indicate the presence of sickle cell, Tay-Sachs, and hemoglobin
Insurers are so adamant about the preceding arguments that to avoid

C traits.

36

state regulations

HTV testing, they are attempting to use other methods to screen applicants without
using HIV testing per se. Some insurers have already utilized screening criteria as diverse
against

as marital status, residence or zip code, medical history, beneficiary,

ments

to screen out persons

The use of HIV screening

who are potentially

at risk for

and living arrange-

AIDS. 37

threatens to create a class of individuals likely to be subject to

AIDS or who are perceived to be at
AIDS have suffered discrimination in employment, housing, accommodations,
and parental rights. 38 Use of HIV screening by insurers increases the risk of discrimina-

discrimination in various aspects of life. Persons with
risk for

tion, particularly since safeguards to protect the confidentiality

of information collected

by insurance companies are inadequate. The failure of the federal government to protect
individuals from discrimination on the basis of their HIV antibody status creates an atmosphere that discourages use of the antibody

test.

Coverage of home care, hospice, and other forms of subacute care. Strategies need to
address the coverage of cost-effective methods of caring for AIDS patients, including
home care, hospice, group residences, skilled nursing facilities, and subacute care units.
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As noted in the
significantly

first

section of this article, the daily costs of care for these services are

lower than acute inpatient

Medicaid programs
to

in

each

state

may

cost.

apply for a waiver that would allow the program

develop more effective reimbursement plans for a particular disease.

received such a waiver for
of-hospital services

AIDS and has established a

which are required

New Jersey has

system for reimbursing those out-

to care for patients with

AIDS in the most humane

and cost-effective manner.
Beginning in FY' 87, Massachusetts allocated funds

to eight

home health care agencies,

in order to assist the agencies in developing services for persons with

have been used for
have argued

staff training, education,

that insufficient

reimbursement

ery of services to persons with

Case management

is

is still

grants

a major impediment to effective deliv-

AIDS, and have looked to

reevaluate the services for which

AIDS. The

and outreach programs. The grant recipients
insurers, primarily Medicaid, to

home health care agencies may

another approach that

is

seek reimbursement.

receiving increased attention as a cost-

effective way of coping with specific medical problems. Under this approach, a case
manager helps develop a strategic plan for the patient. For example, in the case of AIDS
patients, a case management approach may involve educating the family and friends in
order to help them overcome fears of the disease and help them enable the patient to remain at home as long as possible. Blue Cross of Massachusetts has adopted a case management system for elderly patients but has not implemented the program for persons
with AIDS. A study of the effectiveness of case management for AIDS patients is under

way

at the

AIDS Medical Resource Center in Illinois. 39

Shared risk pools. The problem of "uninsurables"
earlier, other classes

is

not a

new

one, and, as indicated

of individuals have had difficulty obtaining health insurance. In

order to maintain private insurer involvement in coverage of high-risk individuals,
teen states have passed legislation establishing risk pool programs. 40

thir-

Under these pro-

grams, private insurers contribute to a pool that provides health insurance to individuals
at

high risk for various diseases. The premiums are generally higher than normal, and

government subsidies keep them within an affordable range. The programs have not been
very successful. In 1986, the seven operating risk pools enrolled only twenty-one thou-

sand people, and

all

but one of the pools lost money. 41 The addition of AIDS patients as

would exacerbate this situation further.
hampered for persons with AIDS not only because of unavailability, but also because of cost of premiums, since an AIDS diagnosis is often accompanied by loss of employment and of the ability to pay for insurance. Therefore, shared risk
pools alone are unlikely to solve the problem of providing health insurance for persons
with AIDS, and may need to be combined with a subsidy or coupon-type program to
beneficiaries of the pool

Access

to insurance is

allow persons with

AIDS to purchase

such insurance.

Suggestions for Managing the Cost of Caring for People
with

AIDS

Reduce acute inpatient care days. Acute inpatient care constitutes the largest single
component of the direct medical care costs of AIDS patients. It is necessary to reduce
acute inpatient care as much as possible without compromising the quality of care each
patient receives. Reduction of inpatient care may be accomplished by establishing an
organized, well-trained, and reimbursable continuum of care.
Physicians must be trained to recognize the opportunistic infections associated with
AIDS in a timely way. They must be familiar with the latest treatments, particularly those
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which allow patients

to

be treated

at

home or at subacute care

facilities.

— including skilled nursing facilities, home health care, hospice
programs, and group residences — must be developed through the utilization of new or
Subacute levels of care

existing resources.

Reimbursements must be

flexible

enough

to

make such

facilities

eco-

nomically feasible.
Target specific medical care providers for assistance. Those institutions or insurers

which provide the greatest amounts of unreimbursed care must be

identified,

and subsi-

Owing to mat-

dies

must be provided

ters

of geography, philosophy, or reputation or to referral networks, certain institutions

to enable the continued delivery of these services.

numbers of AIDS

who are uninsured
who is being disproimpacted as well as the extent of shortfalls related to AIDS care. Accurate

are likely to care for disproportionately high

patients

or underinsured. Adequate systems must be developed to determine
portionately

assessments of the extent of unreimbursed care will assure the most cost-effective

distri-

butions of subsidies or program funds.

AIDS education. Education about AIDS must be strengthened to prevent
While our projections through 1991 indicate a situation that appears to be
economically manageable, worst case scenarios through 1995 and beyond may present a
far less manageable situation. Reducing the number of new infections and thereby reducing the number of new AIDS cases is an important and extremely cost-effective strategy.
Strengthen

new

cases.

Conclusion

The

cost of treating people with

diagnosed in
for society

AIDS, estimated to be more than $500 million

New England over the ten-year period

1981 to 1991

and especially for the health care industry. However,

,

is

for cases

an increasing burden

this cost is

only a small

percentage of overall health care costs and, with proper planning, can be managed.

The largest component of AIDS

health care costs

part of inpatient care costs consists of room

is

acute inpatient care, and the largest

and board. Ambulatory care and home care

are significantly less expensive alternatives.

AIDS is made more difficult by the patchwork nature of the current health
Many persons with AIDS are
uninsured or underinsured, or may lose their insurance coverage during the course of
their illness. Various strategies may be implemented to maintain or perhaps expand insurPaying for

care reimbursement system and distribution of services.

ance coverage for people with AIDS. However, insurers, including Medicare and Medicaid, will

oppose any plan

that increases their share of AIDS coverage.

may find themselves overburdened as they
AIDS patients. Public and teaching hospitals in New
England are likely to be burdened the most by the AIDS epidemic.
To guard against the deterioration of health care services for people with AIDS, the
Particular insurers or health care providers

become the primary care centers

authors

recommend

for

reduction of acute inpatient care through the development of alterna-

tive levels of care, including subacute care, skilled nursing facilities, hospice

programs,

group residences, and home health care; the development of targeted subsidies or programs to relieve severe pressures on particular insurers or health care providers; and the
strengthening of education to slow the growth of the

AIDS epidemic. %#

The Massachusetts Cost ofAIDS Study is a project of the Community Infectious Disease Epidemiology Program (CIDEP) at the Boston Department of Health and Hospitals and the Boston University
School of Public Health
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